ICZOOM Group enters the second week of May in a starkly different configuration from where it was a month ago — a dramatic short unwind has drained the borrow market pressure that defined March and early April, while a Nasdaq compliance deadline sits quietly in the background.
The most striking story in the data is the collapse of short interest. IZM's short position peaked near 900,000 shares in late March, then fell almost 80% over five weeks to roughly 71,500 shares by early May. That is now just 0.87% of the free float — too small to be a meaningful directional signal on its own. What makes the move notable is the speed. Short sellers reduced their exposure by nearly 88% in a single month, a pace that typically reflects either a forced unwind or a swift reassessment of the thesis.
The lending market confirms the unwinding story, though the current conditions look unremarkable. Borrow availability is extremely loose — available shares equal more than 1,000% of outstanding short interest, meaning supply in the lending pool vastly exceeds demand. Cost to borrow has collapsed to just 1.26%, down from a peak above 6% in early April. That April peak, when availability was tightest and CTB ran above 5%, coincided with short interest near its high. Since then, both metrics have normalised sharply. The ORTEX short score, now at 29.9, reflects this easing — it has drifted down from 31.5 over the past two weeks and ranks in the 72nd percentile, suggesting the stock is on watch but not in any extreme territory.
The Nasdaq compliance notification, disclosed on April 14, adds a separate layer of context. ICZOOM received a noncompliance notice and has until October 12 to regain compliance. The stock is priced at $0.38, down about 20% over the past month, which is consistent with a listing-risk discount. The market cap is approximately $3.1 million — firmly micro-cap territory. Institutional ownership is heavily concentrated: the two largest holders, Lei Xia and Duanrong Liu, together hold roughly 35% of shares outstanding. The remaining institutional presence is negligible, with XTX Markets and Jane Street each holding under 20,000 shares as of year-end 2025.
The earnings history adds one more data point worth watching. The last two significant earnings events produced divergent reactions: a 15.5% single-day drop followed by a five-day slide of 28.5%, and before that a 3.5% gain that faded to a 6.7% loss over five days. The next event is flagged for August 31. Between now and then, the Nasdaq compliance deadline in mid-October becomes the more pressing calendar item.
What to watch next is whether the Nasdaq remediation plan ICZOOM files before October 12 includes a reverse stock split, additional equity issuance, or another mechanism to lift the share price back above the minimum bid requirement — any of those paths carries distinct implications for the share count and float.
See the live data behind this article on ORTEX.
Open IZM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
